Updated on 21 October 2025:
New section ''Collaboration with content creators''
EMA adapts and expands its social media presence based on evidence about our users' needs and what we are able to offer them.
We also follow certain accounts on social media. This does not represent an endorsement of their content.
For our news and events, see:
The EMA press office opening hours are Monday to Friday between 09:00 and 18:00 Central European Time.
The press office deals with enquiries from media only.
EMA press office Tel. +31(0)88 781 8427 E-mail: press@ema.europa.eu
Mailing address European Medicines Agency, PO Box 71010, 1008 BA Amsterdam, The Netherlands
For enquiries from the general public and other parties, please see Send a question to the European Medicines Agency.
Journalists can make use of EMA building photos and stock video footage available on the European Commission Audiovisual Service page. The materials can be used free of charge in accordance with the copyright notice.
If you would like to use the EMA logo, follow the instructions in Logo and visual identity.
Our Bluesky handle is ema.europa.eu
Bluesky is a social networking platform where you can post short messages and stay updated with our latest news. It integrates various types of content, including text, photos, and videos. It is a decentralised platform, built on an open-source framework which allows any user to see how it is built and what is being developed.
We use Bluesky to keep you informed about new medicines in the European Union, latest health advancements, public and animal health news.
Additionally, we highlight science, medicines, and health-related posts from other organisations and users active on Bluesky.
Once you join Bluesky, simply click the 'follow' button on our profile to receive all updates directly.
Bluesky gives you the option of choosing the algorithm that drives your experience on the platform. You can also create custom feeds for different topics or interests.
Our YouTube channel is European Medicines Agency.
We use YouTube to publish recorded video and audio content from our major meetings, events and training workshops.
We have also published short videos on themes such as orphan medicines, additional monitoring of medicines and the EU pharmacovigilance legislation.
YouTube is a free content-sharing platform for sharing video and audio recordings.
Separately from YouTube, we also broadcast some of our major events live on the EMA website.
EMA has a LinkedIn profile where we post updates on our activities and related to the evaluation and safety monitoring of medicines, as well as our latest job vacancies.
EMA’s Executive Director, Emer Cooke, is also sharing posts and articles about public health on her influencer LinkedIn account.
LinkedIn is a professional social networking site used by companies, organisations and individuals to create profiles and share information about career opportunities.
EMA, together with the European Food Safety Authority (EFSA), the European Chemicals Agency (ECHA), the European Centre for Disease Prevention and Control (ECDC) and the European Environment Agency (EEA), publish content a joint Instagram account.
We cover topics that impact our health, animals and our planet. These include:
Follow @onehealth_eu
EMA is working with social media content creators. They help us promote important messages on public and animal health to European Union (EU) citizens.
We work with content creators who have a credible presence in healthcare communication and who align with EMA’s values:
When selecting our partner content creators, or influencers, we also ensure balanced geographical representation across EU countries.
EMA partnered with content creators to promote safe and responsible use of GLP-1 medicines for weight loss and diabetes in our #HealthNotHype social media campaign.
For more information on the #HealthNotHype social media campaign, see:
On Facebook you can find a page about EMA. We do not own or manage this page. While Facebook is a widely-used social networking website, we currently do not communicate with our stakeholders using Facebook.
You can find content on EMA and its activities on Wikipedia and other collaborative platforms. This content has been produced independently which we do not oversee.
You can use the 'share' button on each page of the EMA website to share a link to that page with your contacts via your social media accounts.
We invite different views and opinions expressed on our social media channels, but we apply moderation rules when necessary.
We encourage our followers to interact with each other and contribute to ongoing debates in a respectful and constructive manner. We cannot assume responsibility for their comments or behaviour.
We use a number of hashtags (#) in order to join group conversations and be able to participate in relevant debates but we cannot assume responsibility for any content under these hashtags that has not been developed by us.
We reserve the right to disregard or remove content that:
We reserve the right not to reply individually to messages or comments received on social media.
We may revise the content of our terms of engagement on social media at any time and at our own discretion.
For queries on these moderation rules, please contact us via our online form.
Each social media channel has its own policy for processing your personal data.
For example, if you choose to watch one of our videos on YouTube, you are explicitly asked to accept YouTube cookies. Similarly, if you look at our Twitter account, you are explicitly asked to accept Twitter cookies.
The same applies for our presence on LinkedIn and Instagram.
If you have any concerns or questions about how these platforms use your personal data, please read their privacy policies.
EMA monitors aggregated data about its followers on social media platforms using Twitter and LinkedIn analytics.
We offer a range of RSS feeds, which allow you to stay updated on the latest news and features from the EMA website.
RSS feeds automatically deliver content to your RSS news reader, which you need to download and install before subscribing to our feeds. To learn more about RSS and news readers, read our RSS guide.